These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9623977)

  • 21. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
    Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role for the p53 homologue p73 in E2F-1-induced apoptosis.
    Irwin M; Marin MC; Phillips AC; Seelan RS; Smith DI; Liu W; Flores ER; Tsai KY; Jacks T; Vousden KH; Kaelin WG
    Nature; 2000 Oct; 407(6804):645-8. PubMed ID: 11034215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Established cell lines transformed by E2F-1 overexpression contain wild-type p53.
    Sladek TL
    Cell Prolif; 1996 Nov; 29(11):579-88. PubMed ID: 9105415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
    Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA
    Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rb and E2F-1 regulate telomerase activity in human cancer cells.
    Crowe DL; Nguyen DC
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A).
    Amanullah A; Hoffman B; Liebermann DA
    Blood; 2000 Jul; 96(2):475-82. PubMed ID: 10887108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer.
    Elliott MJ; Baker JD; Dong YB; Yang HL; Gleason JF; McMasters KM
    Tumour Biol; 2002; 23(6):324-36. PubMed ID: 12677090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells.
    Mitlianga PG; Gomez-Manzano C; Kyritsis AP; Fueyo J
    Int J Oncol; 2002 Nov; 21(5):1015-20. PubMed ID: 12370749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.
    Lissy NA; Davis PK; Irwin M; Kaelin WG; Dowdy SF
    Nature; 2000 Oct; 407(6804):642-5. PubMed ID: 11034214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
    Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of p16 in the E2F-dependent thymidine kinase regulation.
    Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
    Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos.
    Tsai KY; Hu Y; Macleod KF; Crowley D; Yamasaki L; Jacks T
    Mol Cell; 1998 Sep; 2(3):293-304. PubMed ID: 9774968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo.
    Lee SH; Kim MS; Kwon HC; Park IC; Park MJ; Lee CT; Kim YW; Kim CM; Hong SI
    Int J Mol Med; 2000 Nov; 6(5):559-63. PubMed ID: 11029524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
    Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
    Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
    Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.